Real Estate Contracts & Agreements in the Biotechnology Industry

2,544 Contracts & Agreements

Browse by Subcategory

Lease Agreements (2,532 contracts from 497 companies)
Mortgage Agreements (12 | 6)

Browse by Company

89bio, Inc. (4 contracts)
ACADIA PHARMACEUTICALS INC (10)
ACCELERON PHARMA INC (2)
Achaogen, Inc. (7)
ACHIEVE LIFE SCIENCES, INC. (9)
Acorda Therapeutics (4)
Actinium Pharmaceuticals, Inc. (2)
Acumen Pharmaceuticals, Inc. (2)
Adamas Pharmaceuticals Inc (9)
Adaptimmune Therapeutics PLC (5)
Adhera Therapeutics, Inc. (11)
ADiTx Therapeutics, Inc. (1)
ADMA BIOLOGICS, INC. (3)
ADURO BIOTECH, INC. (4)
Advaxis, Inc. (2)
Adverum Biotechnologies, Inc. (12)
Aeglea BioTherapeutics, Inc. (4)
Aerovate Therapeutics, Inc. (4)
AGENUS INC (23)
AgeX Therapeutics, Inc. (1)
AGIOS PHARMACEUTICALS INC (13)
AILERON THERAPEUTICS INC (4)
Aimmune Therapeutics, Inc. (7)
AKCEA THERAPEUTICS, INC. (6)
Akebia Therapeutics, Inc. (9)
Akero Therapeutics, Inc. (1)
Akouos, Inc. (2)
ALBIREO PHARMA, INC. (9)
Aldeyra Therapeutics, Inc. (8)
Alector, Inc. (2)
Alexion Pharmaceuticals (3)
Aligos Therapeutics, Inc. (2)
Alkermes plc. (6)
Allakos Inc. (3)
Allena Pharmaceuticals, Inc. (4)
Alliqua BioMedical, Inc. (2)
Allogene Therapeutics, Inc. (7)
Allovir, Inc. (5)
ALNYLAM PHARMACEUTICALS, INC. (14)
Alpha Healthcare Acquisition Corp. (5)
ALPINE IMMUNE SCIENCES, INC. (5)
AMARILLO BIOSCIENCES INC (1)
AMARIN CORP PLC (9)
AMICUS THERAPEUTICS, INC. (7)
AmpliPhi Biosciences Corp (11)
ANAPTYSBIO INC (6)
ANAVEX LIFE SCIENCES CORP. (2)
Anika Therapeutics (11)
Annexon, Inc. (2)
Apellis Pharmaceuticals, Inc. (9)
APPLIED GENETIC TECHNOLOGIES CORP (6)
Applied Molecular Transport Inc. (4)
Aptevo Therapeutics Inc. (3)
Aptinyx Inc. (1)
AquaBounty Technologies, Inc. (3)
AQUINOX PHARMACEUTICALS, INC (10)
Aravive, Inc. (4)
Arbutus Biopharma Corp (3)
ARCA biopharma, Inc. (15)
Arcellx, Inc. (1)
Arcturus Therapeutics Holdings Inc. (5)
Arcus Biosciences, Inc. (3)
Arcutis Biotherapeutics, Inc. (2)
ARDELYX, INC. (10)
ARENA PHARMACEUTICALS INC (5)
Aridis Pharmaceuticals, Inc. (1)
ARROWHEAD PHARMACEUTICALS, INC. (9)
Arsanis, Inc. (7)
Artiva Biotherapeutics, Inc. (2)
ARYA Sciences Acquisition Corp II (2)
Atara Biotherapeutics, Inc. (7)
Athenex, Inc. (1)
ATOSSA GENETICS INC (8)
Atreca, Inc. (6)
aTYR PHARMA INC (6)
Aura Biosciences, Inc. (1)
Aurinia Pharmaceuticals Inc. (3)
AVEO PHARMACEUTICALS INC (11)
Avidity Biosciences, Inc. (4)
Avita Therapeutics, Inc. (6)
AVROBIO, Inc. (1)
Axcella Health Inc. (3)
Ayala Pharmaceuticals, Inc. (1)
BCTG Acquisition Corp. (1)
Beam Therapeutics Inc. (5)
BeiGene, Ltd. (1)
BELLICUM PHARMACEUTICALS, INC (11)
BICYCLE THERAPEUTICS Ltd (1)
Big Cypress Acquisition Corp. (2)
BIO-PATH HOLDINGS INC (3)
bioAffinity Technologies, Inc. (2)
BioAtla, Inc. (2)
BioCardia, Inc. (7)
BIOCEPT INC (8)
BIOCRYST PHARMACEUTICALS INC (2)
Biogen Inc. (11)
BIOMARIN PHARMACEUTICAL INC (3)
Biomea Fusion, Inc. (2)
BioRestorative Therapies, Inc. (3)
BIOSPECIFICS TECHNOLOGIES CORP (9)
Biostage, Inc. (1)
BIOTIME INC (7)
BioXcel Therapeutics, Inc. (2)
Black Diamond Therapeutics, Inc. (2)
Blue Water Vaccines Inc. (1)
bluebird bio, Inc. (11)
Blueprint Medicines Corp (6)
Bolt Biotherapeutics, Inc. (4)
BridgeBio Pharma, Inc. (1)
C4 Therapeutics, Inc. (2)
Cabaletta Bio, Inc. (3)
CALADRIUS BIOSCIENCES, INC. (8)
Calithera Biosciences, Inc. (4)
Calyxt, Inc. (1)
CANCER GENETICS, INC (5)
Candel Therapeutics, Inc. (2)
CAPRICOR THERAPEUTICS, INC. (13)
Capstone Therapeutics Corp. (1)
CareDx, Inc. (5)
Caribou Biosciences, Inc. (3)
CASI Pharmaceuticals, Inc. (3)
CASTLE BIOSCIENCES INC (19)
Castle Creek Biosciences, Inc. (3)
CATABASIS PHARMACEUTICALS INC (2)
CATALYST BIOSCIENCES, INC. (5)
CATALYST PHARMACEUTICALS, INC. (7)
Celcuity Inc. (6)
Celldex Therapeutics, Inc. (13)
Cellectar Biosciences, Inc. (3)
Cellular Biomedicine Group, Inc. (6)
Celsion CORP (3)
Centessa Pharmaceuticals Ltd (1)
Chanticleer Holdings, Inc. (1)
Chardan Healthcare Acquisition Corp. (9)
Chelsea Worldwide Inc. (2)
ChemoCentryx, Inc. (6)
CHIMERIX INC (11)
Cidara Therapeutics, Inc. (8)
CM Life Sciences III Inc. (2)
Codiak BioSciences, Inc. (3)
Coherus BioSciences, Inc. (2)
COMPASS Pathways plc (1)
Conatus Pharmaceuticals Inc. (7)
CONCERT PHARMACEUTICALS, INC. (2)
Consonance-HFW Acquisition Corp. (3)
Constellation Alpha Capital Corp. (8)
CONSTELLATION PHARMACEUTICALS INC (4)
CONTRAFECT Corp (2)
Corbus Pharmaceuticals Holdings, Inc. (7)
Cortexyme, Inc. (2)
Corvus Pharmaceuticals, Inc. (5)
Crinetics Pharmaceuticals, Inc. (2)
CRISPR Therapeutics AG (7)
CTD HOLDINGS INC (2)
CTI BIOPHARMA CORP (4)
Cullinan Oncology, LLC (1)
CURIS INC (4)
Cyclacel Pharmaceuticals, Inc. (6)
Cyclerion Therapeutics, Inc. (3)
Cytokinetics, Incorporated (10)
CytomX Therapeutics, Inc. (2)
CYTORI THERAPEUTICS, INC. (7)
CYTRX CORP (7)
Day One Biopharmaceuticals Holding Co LLC (2)
DBV Technologies S.A. (2)
Decibel Therapeutics, Inc. (2)
Deciphera Pharmaceuticals, Inc. (4)
Denali Therapeutics Inc. (2)
Dermavant Sciences Ltd (3)
Dermira, Inc. (4)
Design Therapeutics, Inc. (2)
DiaMedica Therapeutics Inc. (6)
Dicerna Pharmaceuticals Inc (5)
Diffusion Pharmaceuticals Inc. (2)
DYADIC INTERNATIONAL INC (5)
Dynamics Special Purpose Corp. (8)
DYNAVAX TECHNOLOGIES CORP (9)
Dyne Therapeutics, Inc. (5)
Eagle Pharmaceuticals, Inc. (2)
Edge Therapeutics, Inc. (2)
Editas Medicine, Inc. (1)
Eidos Therapeutics, Inc. (3)
Eiger BioPharmaceuticals, Inc. (5)
Emerald Bioscience, Inc. (4)
Emergent BioSolutions Inc. (7)
Enanta Pharmaceuticals, Inc. (8)
Enochian Biosciences Inc (4)
Entrada Therapeutics, Inc. (2)
Environmental Impact Acquisition Corp (4)
ENZON PHARMACEUTICALS, INC. (2)
Epizyme, Inc. (7)
Equillium, Inc. (1)
Erasca, Inc. (2)
Esperion Therapeutics, Inc. (7)
Evelo Biosciences, Inc. (3)
EXACT SCIENCES CORP (13)
Exelixis (35)
EXICURE, INC. (5)
FATE THERAPEUTICS INC (9)
FENNEC PHARMACEUTICALS INC. (2)
Fibrocell Science, Inc. (3)
FIBROGEN INC (1)
Finch Therapeutics Group, Inc. (4)
FIVE PRIME THERAPEUTICS INC (5)
Flex Pharma, Inc. (2)
Flexion Therapeutics Inc (10)
FLUOROPHARMA MEDICAL, INC. (2)
Foghorn Therapeutics Inc. (3)
Forma Therapeutics Holdings, Inc., (4)
Forty Seven, Inc. (3)
Frequency Therapeutics, Inc. (8)
FS Development Corp. (2)
Fusion Pharmaceuticals Inc. (4)
G1 Therapeutics, Inc. (2)
GALECTIN THERAPEUTICS INC (1)
Galecto Inc. (2)
Gemphire Therapeutics Inc. (6)
Gene Biotherapeutics, Inc. (3)
GENELUX CORP (4)
Generation Bio Co. (3)
GENOCEA BIOSCIENCES, INC. (5)
GeoVax Labs, Inc. (5)
GERON CORP (9)
Global Blood Therapeutics, Inc. (5)
GLYCOMIMETICS INC (5)
GOLDENWELL BIOTECH, INC. (1)
Gossamer Bio, Inc. (3)
Grail, Inc. (3)
Graphite Bio, Inc. (5)
Gritstone Oncology, Inc. (8)
GT Biopharma, Inc. (2)
GTX INC (8)
GX Acquisition Corp. (3)
HALOZYME THERAPEUTICS INC (8)
HARBOR DIVERSIFIED, INC. (1)
Harpoon Therapeutics, Inc. (3)
HCW Biologics Inc. (1)
HEAT BIOLOGICS, INC. (8)
HedgePath Pharmaceuticals, Inc. (1)
HEMISPHERX BIOPHARMA INC (6)
HERON THERAPEUTICS, INC. (9)
HISTOGENICS CORP (8)
Homology Medicines, Inc. (4)
HOOKIPA Pharma Inc. (2)
HUMANIGEN, INC (2)
iBio, Inc. (2)
Icosavax, Inc. (1)
IDEAYA Biosciences, Inc. (5)
IDERA PHARMACEUTICALS, INC. (4)
IGM Biosciences, Inc. (2)
IMMUNE PHARMACEUTICALS INC (1)
Immuneering Corp (1)
ImmunoCellular Therapeutics, Ltd. (1)
IMMUNOGEN INC (13)
IMMUNOMEDICS INC (1)
IMPEL NEUROPHARMA INC (1)
IN8BIO, INC. (7)
Incyte (5)
INFINITY PHARMACEUTICALS, INC. (14)
Inhibikase Therapeutics, Inc. (1)
Inhibrx, Inc. (2)
InMed Pharmaceuticals Inc. (1)
Inmune Bio, Inc. (1)
INOVIO PHARMACEUTICALS, INC. (4)
Inozyme Pharma, Inc. (2)
INSMED Inc (12)
Intellia Therapeutics, Inc. (6)
INTERCEPT PHARMACEUTICALS, INC. (11)
International Stem Cell CORP (6)
Invitae Corp (4)
IONIS PHARMACEUTICALS INC (4)
IOVANCE BIOTHERAPEUTICS, INC. (11)
IRONWOOD PHARMACEUTICALS INC (16)
Isoray, Inc. (4)
iTeos Therapeutics, Inc. (1)
Janux Therapeutics, Inc. (1)
Jounce Therapeutics, Inc. (4)
Kadmon Holdings, Inc. (2)
KalVista Pharmaceuticals, Inc. (6)
Karuna Therapeutics, Inc. (2)
Karyopharm Therapeutics Inc. (7)
Keros Therapeutics, Inc. (3)
Kezar Life Sciences, Inc. (2)
Kindred Biosciences, Inc. (4)
Kiniksa Pharmaceuticals, Ltd. (5)
Kinnate Biopharma Inc. (2)
Kiromic Biopharma, Inc. (6)
KIWA BIO-TECH PRODUCTS GROUP CORP (1)
Kodiak Sciences Inc. (1)
Kronos Bio, Inc. (1)
Krystal Biotech, Inc. (17)
Kura Oncology, Inc. (15)
Kymera Therapeutics, Inc. (1)
LEAP THERAPEUTICS, INC. (9)
LEXICON PHARMACEUTICALS, INC. (1)
LianBio (5)
LifeSci Acquisition Corp. (1)
Ligand Pharmaceuticals Incorporated (7)
Locust Walk Acquisition Corp. (2)
LogicBio Therapeutics, Inc. (1)
LONGEVERON LLC (1)
Lyell Immunopharma, Inc. (5)
MACROGENICS INC (12)
MADRIGAL PHARMACEUTICALS, INC. (6)
Magenta Therapeutics, Inc. (4)
MANNKIND CORP (3)
MARIZYME INC (2)
MATEON THERAPEUTICS INC (8)
Matinas BioPharma Holdings, Inc. (2)
MAXCYTE, INC. (9)
MEDICINOVA INC (2)
MeiraGTx Holdings plc (9)
MERRIMACK PHARMACEUTICALS INC (12)
Mersana Therapeutics, Inc. (4)
Merus N.V. (3)
Metacrine, Inc. (2)
Millendo Therapeutics, Inc. (7)
MiMedx Group, Inc. (11)
Minerva Neurosciences, Inc. (1)
MIRAGEN THERAPEUTICS, INC. (14)
Mirati Therapeutics, Inc. (9)
Mirum Pharmaceuticals, Inc. (4)
Moderna, Inc. (2)
Molecular Templates, Inc. (12)
Moleculin Biotech, Inc. (2)
Momenta Pharmaceuticals, Inc. (16)
Monte Rosa Therapeutics, Inc. (3)
Morphic Holding, Inc. (3)
MUSTANG BIO, INC. (5)
Myriad Genetics, Inc. (13)
NANOVIRICIDES, INC. (1)
NantKwest, Inc. (22)
Natera, Inc. (5)
NAVIDEA BIOPHARMACEUTICALS, INC. (1)
NEUROBIOLOGICAL TECHNOLOGIES INC (4)
NEUROCRINE BIOSCIENCES INC (5)
Neurotrope, Inc. (1)
NexImmune, Inc. (2)
NextCure, Inc. (4)
Nkarta, Inc. (11)
NORTHWEST BIOTHERAPEUTICS INC (4)
NOVAVAX INC (27)
Novus Therapeutics, Inc. (6)
NTN BUZZTIME INC (15)
Nurix Therapeutics, Inc. (10)
Ohr Pharmaceutical Inc (10)
Olivia Ventures, Inc. (2)
Omega Therapeutics, Inc. (5)
OncoCyte Corp (6)
Oncorus, Inc. (6)
ONCOSEC MEDICAL Inc (8)
OPGEN INC (10)
Ophthotech Corp. (7)
Opko Health, Inc. (2)
ORAGENICS INC (3)
Orchard Therapeutics plc (1)
Organicell Regenerative Medicine, Inc. (1)
Organogenesis Holdings Inc. (10)
ORGANOVO HOLDINGS, INC. (7)
Oric Pharmaceuticals, Inc. (2)
Outlook Therapeutics, Inc. (8)
Passage BIO, Inc. (4)
PDL BIOPHARMA, INC. (10)
Pfenex Inc. (4)
PhaseBio Pharmaceuticals Inc (1)
Phio Pharmaceuticals Corp. (4)
PIERIS PHARMACEUTICALS, INC. (6)
PLURISTEM THERAPEUTICS INC (1)
PMV Pharmaceuticals, Inc. (3)
POLARITYTE, INC. (7)
PORTOLA PHARMACEUTICALS INC (3)
Poseida Therapeutics, Inc. (4)
Praxis Precision Medicines, Inc. (3)
PRECISION BIOSCIENCES INC (10)
Prelude Therapeutics Inc (3)
Prevail Therapeutics Inc. (1)
Principia Biopharma Inc. (3)
Progenics Pharmaceuticals, Inc. (3)
Prometheus Biosciences, Inc. (2)
Protagenic Therapeutics, Inc. (2)
Protagonist Therapeutics, Inc (9)
Protalix BioTherapeutics, Inc. (2)
PROTEON THERAPEUTICS INC (3)
PROTEOSTASIS THERAPEUTICS, INC. (10)
Prothena Corp plc (3)
PTC THERAPEUTICS, INC. (5)
PUMA BIOTECHNOLOGY, INC. (5)
Pyxis Oncology, Inc. (1)
Radius Health, Inc. (11)
RAPT Therapeutics, Inc. (4)
RECURSION PHARMACEUTICALS, INC. (10)
Regeneron Pharmaceuticals (18)
REGENXBIO Inc. (14)
Regulus Therapeutics Inc. (12)
Relay Therapeutics, Inc. (1)
Repare Therapeutics Inc. (12)
Replimune Group, Inc. (3)
Retrophin, Inc. (1)
Revolution Medicines, Inc. (12)
REXAHN PHARMACEUTICALS, INC. (13)
Rezolute, Inc. (2)
RHYTHM PHARMACEUTICALS, INC. (4)
RIGEL PHARMACEUTICALS INC (8)
RITTER PHARMACEUTICALS INC (2)
ROCKET PHARMACEUTICALS, INC. (9)
Rubius Therapeutics, Inc. (2)
Sage Therapeutics, Inc. (10)
Sana Biotechnology, Inc. (2)
SANGAMO THERAPEUTICS, INC (11)
Sarepta Therapeutics, Inc. (12)
Savara Inc (6)
Scholar Rock Holding Corp (2)
SEATTLE GENETICS INC (8)
SELECTA BIOSCIENCES INC (9)
SELLAS Life Sciences Group, Inc. (8)
Sensei Biotherapeutics, Inc. (1)
SERA PROGNOSTICS, INC. (4)
Seres Therapeutics, Inc. (5)
Sesen Bio, Inc. (3)
Shattuck Labs, Inc. (2)
Sierra Oncology, Inc. (6)
Sigilon Therapeutics, Inc. (5)
Silverback Therapeutics, Inc. (4)
SOLENO THERAPEUTICS INC (3)
Solid Biosciences Inc. (4)
SOLIGENIX, INC. (2)
SOPHIRIS BIO INC. (1)
Sorrento Therapeutics, Inc. (6)
Spectrum Pharmaceuticals, Inc. (8)
Spero Therapeutics, Inc. (3)
SPHERIX INC (1)
Spinning Eagle Acquisition Corp. (4)
Spring Bank Pharmaceuticals, Inc. (5)
SpringWorks Therapeutics, Inc. (1)
SPRUCE BIOSCIENCES, INC. (2)
SQZ Biotechnologies Co (1)
Stellar Biotechnologies, Inc. (7)
Stoke Therapeutics, Inc. (5)
Summit Therapeutics Inc. (2)
SUNESIS PHARMACEUTICALS INC (11)
Surface Oncology, Inc. (3)
SUTRO BIOPHARMA, INC. (2)
SYNLOGIC, INC. (5)
Synthetic Biologics, Inc. (2)
Syros Pharmaceuticals, Inc. (2)
T2 Biosystems, Inc. (11)
Talaris Therapeutics, Inc. (2)
Taysha Gene Therapies, Inc. (2)
TCR2 THERAPEUTICS INC. (3)
TENAX THERAPEUTICS, INC. (2)
Tenaya Therapeutics, Inc. (3)
Tocagen Inc (6)
Tonix Pharmaceuticals Holding Corp. (3)
Tracon Pharmaceuticals, Inc. (2)
Translate Bio, Inc. (1)
TREVENA INC (8)
Trovagene, Inc. (5)
TScan Therapeutics, Inc. (3)
Turning Point Therapeutics, Inc. (7)
Twist Bioscience Corp (12)
Tyra Biosciences, Inc. (4)
U.S. Stem Cell, Inc. (5)
Ultragenyx Pharmaceutical Inc. (18)
uniQure N.V. (5)
Unity Biotechnology, Inc. (2)
Unum Therapeutics Inc. (4)
UroGen Pharma Ltd. (2)
Vanda Pharmaceuticals Inc. (11)
Vaxart, Inc. (5)
Vaxcyte, Inc. (6)
VBI Vaccines Inc (16)
VERACYTE, INC. (5)
Verastem, Inc. (3)
Vericel Corp (4)
Vertex Pharmaceuticals Inc (9)
Verve Therapeutics, Inc. (4)
VICAL INC (4)
Viela Bio, Inc. (1)
Vigil Neuroscience, Inc. (1)
Viking Therapeutics, Inc. (4)
Vir Biotechnology, Inc. (2)
VistaGen Therapeutics, Inc. (3)
VITAL THERAPIES INC (4)
VITRO DIAGNOSTICS INC (1)
Vor Biopharma Inc. (3)
Voyager Therapeutics, Inc. (10)
Werewolf Therapeutics, Inc. (3)
WINDTREE THERAPEUTICS INC (8)
XBiotech Inc. (4)
Xencor Inc (10)
Xenetic Biosciences, Inc. (2)
Xenon Pharmaceuticals Inc. (5)
Xilio Therapeutics, Inc. (1)
XOMA Corp (10)
Y-mAbs Therapeutics, Inc. (2)
YIELD10 BIOSCIENCE, INC. (7)
ZAFGEN, INC. (8)
Zai Lab Ltd (1)
Zentalis Pharmaceuticals, LLC (10)
ZIOPHARM ONCOLOGY INC (5)
Zymeworks Inc. (2)

Recent Contracts

Third Amendment to Lease Agreement, dated as of September 13, 2024, between ARE-MA REGION NO. 75, LLC and the Company (Enanta Pharmaceuticals, Inc., Filed With SEC on November 27, 2024)
Second Amendment to Lease Agreement, dated as of July 26, 2024, between ARE-MA REGION NO. 75, LLC and the Company (Enanta Pharmaceuticals, Inc., Filed With SEC on November 27, 2024)
September 19, 2024 Lease extension for Riverton office (HEMISPHERX BIOPHARMA INC, Filed With SEC on November 14, 2024)
Sublease Agreement by and among the Company, BKPBIOTECH, Inc. and JLSA2 Therapeutics, Inc., dated as of September 23, 2024 (Dynamics Special Purpose Corp., Filed With SEC on November 14, 2024)
Second Amendment, dated September 24, 2024, to the Lease, dated as of February 11, 2019, between the Registrant and Brandywine Cira, L.P., as amended (Cabaletta Bio, Inc., Filed With SEC on November 14, 2024)
Amendment No. 7 to Commercial Lease, dated October 30 2024, between Columbus Day Realty, Inc. and T2 Biosystems, Inc (T2 Biosystems, Inc., Filed With SEC on November 14, 2024)
Seventh Amendment to Facilities Lease, dated as of September 26, 2023, by and between Capricor, Inc. and Cedars-Sinai Medical Center (CAPRICOR THERAPEUTICS, INC., Filed With SEC on November 14, 2024)
Second Amendment to Lease Agreement, dated October 23, 2024, by and between the Company and the registered holders of GS Mortgage Securities Corporation II, Commercial Mortgage... (BIO-PATH HOLDINGS INC, Filed With SEC on November 14, 2024)
First Amendment to Lease by and between the Company and Plastino II, LP, dated August 21, 2024 (SUNESIS PHARMACEUTICALS INC, Filed With SEC on November 13, 2024)
Sublease Termination Agreement, dated August 9, 2024, between Eterna Therapeutics Inc. and E.R. Squibb & Sons, L.L.C (NTN BUZZTIME INC, Filed With SEC on November 12, 2024)
Second Amendment to Lease by and between Disc Medicine, Inc. and ARE-MA Region No. 75. LLC, dated August 29, 2024 (FS Development Corp., Filed With SEC on November 12, 2024)
SECOND AMENDMENT TO LEASE AGREEMENT (Suite 270) (IN8BIO, INC., Filed With SEC on November 12, 2024)
SECOND AMENDMENT TO LEASE AGREEMENT (Suite 230) (IN8BIO, INC., Filed With SEC on November 12, 2024)
Lease Agreement, effective as of September 27, 2024, by and between Ice Box, LLC and Compass Therapeutics, Inc (Olivia Ventures, Inc., Filed With SEC on November 12, 2024)
Lease Agreement, dated April 25, 2022 between Korro Bio Ops, Inc. (formerly known as Korro Bio, Inc.) and NW Cambridge Property Owner LLC (Frequency Therapeutics, Inc., Filed With SEC on November 12, 2024)
Fifth Amendment to Lease by and between Registrant and Watch City Ventures MT, LLC dated as of September 19, 2024 (MIRAGEN THERAPEUTICS, INC., Filed With SEC on November 12, 2024)
Lease Agreement dated September 11, 2024, by and between the Registrant and Princeton 202 Associates Limited Partnership (Y-mAbs Therapeutics, Inc., Filed With SEC on November 8, 2024)
Sixth Amendment to Lease, dated November 5, 2024, by and between the Company and TCD 234 MA WELLS PROPERTY LLC (Karyopharm Therapeutics Inc., Filed With SEC on November 8, 2024)
First Amendment to the Lease Agreement by and between the registrant, Repare Therapeutics Inc. and RREEF America REIT II Corp. PPP, dated August 26, 2024 (Repare Therapeutics Inc., Filed With SEC on November 7, 2024)
Office Sublease by and between 89bio, Inc. and Sender, Inc., dated as of October 20, 2023 (89bio, Inc., Filed With SEC on November 7, 2024)
Fifth Amendment to Lease, by and between Arcturus Therapeutics, Inc. and ARE-SD Region No. 44, LLC, dated July 12, 2024 (Arcturus Therapeutics Holdings Inc., Filed With SEC on November 7, 2024)
First Amendment to Lease Agreement between the registrant and Hartco Ventura Inc. dated September 12, 2024 (Avita Therapeutics, Inc., Filed With SEC on November 7, 2024)
Second Amendment to Lease Agreement by and between 7495 RP, LLC and Cartesian Therapeutics, Inc. dated August 30, 2024 (SELECTA BIOSCIENCES INC, Filed With SEC on November 7, 2024)
Sixth Amendment to Lease, dated July 30, 2024, by and between KR Oyster Point 1, LLC, and Cytokinetics, Incorporated (Cytokinetics, Incorporated, Filed With SEC on November 7, 2024)
Sixth Amendment, dated as of July 12, 2024, to Lease by and between HCP LS Redwood City, LLC and Revolution Medicines, Inc (Revolution Medicines, Inc., Filed With SEC on November 6, 2024)
2024 Amendment to Lease (11 Fan Pier Boulevard), dated August 15, 2024, between Vertex Pharmaceuticals Incorporated and SNH Seaport LLC (Vertex Pharmaceuticals Inc, Filed With SEC on November 5, 2024)
2024 Amendment to the Lease (50 Northern Avenue), dated August 15, 2024, between Vertex Pharmaceuticals Incorporated and SNH Seaport LLC (Vertex Pharmaceuticals Inc, Filed With SEC on November 5, 2024)
Confirmation of Amendment Provisions, dated as of August 8, 2024, to the Lease Agreement, dated April 1, 2022, by and between the Registrant and ACA Concourse East Unit 3 LLC (CASTLE BIOSCIENCES INC, Filed With SEC on November 4, 2024)
Third Amendment to Lease Agreement, dated September 13, 2024, by and between ARE-San Francisco No. 19 Owner, LLC and the Registrant (Nurix Therapeutics, Inc., Filed With SEC on October 11, 2024)
Fifth Amendment to Lease Agreement, dated September 13, 2024, by and between ARE-San Francisco No. 26 Owner, LLC and the Registrant (Nurix Therapeutics, Inc., Filed With SEC on October 11, 2024)
Fourth Amendment to Lease Agreement, dated April 30, 2021, by and between ARE-San Francisco No. 26 Owner, LLC and the Registrant (Nurix Therapeutics, Inc., Filed With SEC on October 11, 2024)
Third Amendment to Lease Agreement, dated March 2, 2021, by and between ARE-San Francisco No. 26 Owner, LLC and the Registrant (Nurix Therapeutics, Inc., Filed With SEC on October 11, 2024)
Sixth Amendment to Lease, dated May 25, 2021, by and between Ardelyx, Inc. and 34175 Ardenwood Venture, LLC (ARDELYX, INC., Filed With SEC on October 9, 2024)
Lease Agreement, dated October 3, 2024, by and between Ardelyx, Inc. and BMR-Pacific Research Center LP (ARDELYX, INC., Filed With SEC on October 9, 2024)
First Amendment to Lease, by and between Surrozen Operating, Inc. and HCP Oyster Point III LLC, dated October 1, 2024 (Consonance-HFW Acquisition Corp., Filed With SEC on October 2, 2024)
Office Lease Agreement by and between the Registrant and OC 990 Corporate Center Associates, LLC dated July 22, 2024 (KalVista Pharmaceuticals, Inc., Filed With SEC on September 5, 2024)
Landlord Consent to Assignment and Assumption of Lease dated February 1, 2024 by and among Presidio Trust, Kinnate Biopharma Inc., and Eventbrite, Inc (XOMA Corp, Filed With SEC on August 13, 2024)
Net Office Lease dated August 5, 2021 between Presidio Trust and Kinnate Biopharma Inc (XOMA Corp, Filed With SEC on August 13, 2024)
Sublease Agreement by and between the Company and GeneFab (Dynamics Special Purpose Corp., Filed With SEC on August 13, 2024)
Second Amendment to Office Building Net Lease Agreement effective as of May 10, 2024 (Gritstone Oncology, Inc., Filed With SEC on August 13, 2024)